Teva reaches $1.2B settlement with the FTC

Teva Pharmaceuticals Industries has agreed to pay $1.2 billion to settle charges that Chester County-based Cephalon, which Teva acquired in 2011, illegally blocked the launch of generic versions of its sleep disorder drug Provigil. The settlement reached with the Federal Trade Commission is part of the agency's ongoing efforts to crackdown on "pay-for-delay" deals, under which the makers of brand name prescription drug products allegedly work out agreements with generic drug pharmaceuticals to delay…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news